180 Life Sciences Corp.

10.27-0.1800-1.72%Vol 216.40K1Y Perf -7.41%
Jun 18th, 2021 16:00 DELAYED
BID10.07 ASK10.27
Open10.32 Previous Close10.45
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap185.19M 
Earnings Rating
Price Range Ratio 52W %
75.07 
Earnings Date
-

Today's Price Range

9.9810.61

52W Range

1.9013.05

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-3.75%
1 Month
37.30%
3 Months
63.02%
6 Months
270.76%
1 Year
-7.41%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ATNF10.27-0.1800-1.72
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume216.40K
Shares Outstanding18.03M
Trades Count1.62K
Dollar Volume4.67M
Avg. Volume2.03M
Avg. Weekly Volume205.84K
Avg. Monthly Volume368.42K
Avg. Quarterly Volume2.36M

180 Life Sciences Corp. (NASDAQ: ATNF) stock closed at 10.27 per share at the end of the most recent trading day (a -1.72% change compared to the prior day closing price) with a volume of 216.40K shares and market capitalization of 185.19M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 0 people. 180 Life Sciences Corp. CEO is James N. Woody.

The one-year performance of 180 Life Sciences Corp. stock is -7.41%, while year-to-date (YTD) performance is 276.19%. ATNF stock has a five-year performance of %. Its 52-week range is between 1.9 and 13.05, which gives ATNF stock a 52-week price range ratio of 75.07%

180 Life Sciences Corp. currently has a PE ratio of 387.10, a price-to-book (PB) ratio of 1.07, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -%, a ROC of -4.45% and a ROE of -%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from 180 Life Sciences Corp., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. 180 Life Sciences Corp.’s next earnings report date is -.

The consensus rating of Wall Street analysts for 180 Life Sciences Corp. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for 180 Life Sciences Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

180 Life Sciences Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

180 Life Sciences Corp. has a Buy technical analysis rating based on Technical Indicators (ADX : 24.06, ATR14 : 0.79, CCI20 : 51.86, Chaikin Money Flow : 0.03, MACD : 0.56, Money Flow Index : 63.53, ROC : 12.86, RSI : 56.61, STOCH (14,3) : 51.48, STOCH RSI : 0.00, UO : 54.21, Williams %R : -48.52), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of 180 Life Sciences Corp. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

180 Life Sciences Corp.

180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

CEO: James N. Woody

Telephone: +1 302 502-2727

Address: 830 Menlo Avenue, Menlo Park 94025, CA, US

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

Bearish Bullish

67%33%

News

Stocktwits